VIA Pharmaceuticals (VIA Pharmaceuticals) EV-to-EBITDA : 0.00 (As of Jun. 21, 2024)

VIA Pharmaceuticals EV-to-EBITDA Chart

VIA Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
EV-to-EBITDA		Get a 7-Day Free Trial					-1.51	-1.37	0.03	-0.91	-2.52

VIA Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of VIA Pharmaceuticals's EV-to-EBITDA

For the Biotechnology subindustry, VIA Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIA Pharmaceuticals's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIA Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where VIA Pharmaceuticals's EV-to-EBITDA falls into.

VIA Pharmaceuticals EV-to-EBITDA Calculation

VIA Pharmaceuticals's EV-to-EBITDA for today is calculated as:

VIA Pharmaceuticals's current Enterprise Value is $0.00 Mil.
VIA Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VIA Pharmaceuticals  (GREY:VIAP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

VIA Pharmaceuticals's PE Ratio for today is calculated as:

VIA Pharmaceuticals's share price for today is $0.0005.
VIA Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.470.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

VIA Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of VIA Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

VIA Pharmaceuticals (VIA Pharmaceuticals) Business Description